The worldwide vaccines market excluding North America, European Union members and Japan, probably expanded 11 percent to $6.78 billion last year and will increase about 10 percent annually for the next five years, researcher Kalorama Information said.
Slightly higher growth than developed markets at 8-9%. The citation is timely because Tadataka “Tachi” Yamada, the new head of Takeda, wants to direct efforts to these countries.
Article: http://www.businessweek.com/news/2012-05-31/gates-foundation-veteran-yamada-retools-drugmaker-takeda-health
